Barclays
OGN icon

Barclays’s Organon & Co OGN Stock Holding History

Barclays’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
106,976
+74,535
+230% +$891K ﹤0.01% 2560
2026
Q1 		$194K Sell
32,441
-33,459
-51% -$252K ﹤0.01% 3703
2025
Q4 		$473K Sell
65,900
-61,550
-48% -$486K ﹤0.01% 3878
2025
Q3 		$1.36M Sell
127,450
-55,131
-30% -$541K ﹤0.01% 3175
2025
Q2 		$1.77M Buy
182,581
+45,581
+33% +$470K ﹤0.01% 2948
2025
Q1 		$2.04M Buy
137,000
+32,957
+32% +$507K ﹤0.01% 2615
2024
Q4 		$1.55M Sell
104,043
-15,440
-13% -$252K ﹤0.01% 3089
2024
Q3 		$2.29M Buy
119,483
+84,136
+238% +$1.74M ﹤0.01% 2752
2024
Q2 		$732K Sell
35,347
-232,205
-87% -$4.61M ﹤0.01% 2794
2024
Q1 		$5.03M Buy
267,552
+47,085
+21% +$808K ﹤0.01% 1847
2023
Q4 		$3.18M Sell
220,467
-241,647
-52% -$3.29M ﹤0.01% 2503
2023
Q3 		$8.02M Buy
462,114
+131,725
+40% +$2.75M 0.01% 1091
2023
Q2 		$6.88M Buy
330,389
+250,072
+311% +$5.44M ﹤0.01% 1165
2023
Q1 		$1.89M Sell
80,317
-104,496
-57% -$2.81M ﹤0.01% 2237
2022
Q4 		$5.16M Buy
184,813
+13,943
+8% +$357K ﹤0.01% 1599
2022
Q3 		$4M Buy
170,870
+29,261
+21% +$883K ﹤0.01% 1302
2022
Q2 		$4.78M Sell
141,609
-134,559
-49% -$4.71M ﹤0.01% 1370
2022
Q1 		$9.65M Buy
+276,168
New +$9.44M 0.01% 921

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Barclays's OGN Position: Q2 2026 in Review

Barclays increased its Organon & Co (OGN) stake by 230% in Q2 2026, buying an estimated $891K and bringing the position to 106,976 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Barclays first reported a position in OGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.65M in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Barclays held 106,976 shares of Organon & Co worth $1.45M as of Q2 2026.
  • Barclays bought 74,535 Organon & Co shares in Q2 2026, an estimated $891K.
  • Organon & Co made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2560 holding.
  • Barclays first reported a position in Organon & Co in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Organon & Co position peaked at $9.65M in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.